The Food and Drug Administration has approved the first long-acting injectable medication for use as pre-exposure prevention, or PrEP, against HIV, the agency
— will make adherence easier, help increase PrEP usage and drive down the national HIV rate.
Kenyon Farrow, the managing director of PrEP4All, an advocacy group that fights to increase access to HIV prevention and treatment, said his organization is “definitely happy to see the FDA approval of another option for people who want to use PrEP.”
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA approves first injectable HIV prevention drugThe Food and Drug Administration has approved the first long-acting injectable medication for use as pre-exposure prevention, or PrEP, against HIV, the agency
Weiterlesen »
U.S. FDA set to authorize Pfizer, Merck COVID-19 pills this week - Bloomberg NewsThe U.S. Food and Drug Administration is set to authorize COVID-19 treatment pills from both Pfizer Inc and Merck as early as Wednesday, Bloomberg News reported on Tuesday, citing people familiar with the matter.
Weiterlesen »
FDA Will Permanently Allow Abortion Pills to Be Sent by MailThe decision immediately makes permanent the system that was set up at the start of the COVID-19 pandemic to allow patients to get abortion pills after a telemedicine visit rather than going to a doctor's office
Weiterlesen »
Omicron: South African scientists probe link between variants and untreated HIVCovid variants may be mutating inside people with suppressed immunity.
Weiterlesen »
FDA approves first injectable HIV prevention drugThe Food and Drug Administration has approved the first long-acting injectable medication for use as pre-exposure prevention, or PrEP, against HIV, the agency
Weiterlesen »